Goldman Sachs’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-232,325
| Closed | -$2.3M | – | 5839 |
|
|
2022
Q2 | $2.3M | Sell |
232,325
-900
| -0.4% | -$8.91K | ﹤0.01% | 3327 |
|
|
2022
Q1 | $2.3M | Hold |
233,225
| – | – | ﹤0.01% | 3477 |
|
|
2021
Q4 | $2.3M | Sell |
233,225
-1,194
| -0.5% | -$11.7K | ﹤0.01% | 3406 |
|
|
2021
Q3 | $2.28M | Sell |
234,419
-600
| -0.3% | -$5.84K | ﹤0.01% | 3372 |
|
|
2021
Q2 | $2.27M | Buy |
235,019
+174,915
| +291% | +$1.69M | ﹤0.01% | 3410 |
|
|
2021
Q1 | $584K | Buy |
+60,104
| New | +$584K | ﹤0.01% | 4253 |
|